COVID-19 Update: We are currently shipping orders daily. However, due to transit disruptions in some geographies, deliveries may be delayed. To provide all customers with timely access to content, we are offering 50% off our Print & eBook bundle option. Terms & conditions.
Nanotechnology Based Approaches for Tuberculosis Treatment - 1st Edition - ISBN: 9780128198117

Nanotechnology Based Approaches for Tuberculosis Treatment

1st Edition

0.0 star rating Write a review
Editor: Prashant Kesharwani
Paperback ISBN: 9780128198117
Imprint: Academic Press
Published Date: 19th June 2020
Page Count: 284
Sales tax will be calculated at check-out Price includes VAT/GST

Institutional Subscription

Secure Checkout

Personal information is secured with SSL technology.

Free Shipping

Free global shipping
No minimum order.

Description

Nanotechnology Based Approaches for Tuberculosis Treatment discusses multiple nanotechnology-based approaches that may help overcome persisting limitations of conventional and traditional treatments. The book summarizes the types of nano drugs, their synthesis, formulation, characterization and applications, along with the most important administration routes. It also explores recent advances and achievements regarding therapeutic efficacy and provides possible future applications in this field. It will be a useful resource for investigators, pharmaceutical researchers, innovators and scientists working on technology advancements in the areas of targeted therapies, nano scale imaging systems, and diagnostic modalities in tuberculosis.

Key Features

  • Addresses the gap between nanomedicine late discovery and early development of tuberculosis therapeutics
  • Explores tuberculosis nanomedicine standardization and characterization with newly developed treatment, diagnostic and treatment monitoring modalities
  • Covers the field thoroughly, from the pathogenesis of tuberculosis and multi-drug resistant mycobacterium tuberculosis, to treatment approaches using nanotechnology and different nanocarriers

Readership

Researchers, early-career investigators, and graduate students working in the pharmaceutical industries, nanomedicine, or infectious diseases

Table of Contents

  1. Pathogenesis, biology, and immunology of tuberculosis
    RAVI BANDARU, DEVIPRASAD SAHOO, RAMAKANTA NAIK, PRASHANT KESHARWANI AND RAMBABU DANDELA
    2. Tuberculosis: introduction, drug regimens, and multidrug-resistance
    SIMA SINGH, NEELAM DHANKAR, ASHISH KUMAR GARG AND PRASHANT KESHARWANI
    3. Nanotechnology as a potential tool against drug- and multidrug-resistant tuberculosis
    DAMIÁN EDUARDO PÉREZ-MARTÍNEZ AND ROBERTO ZENTENO-CUEVAS
    4. Translational research for therapy against tuberculosis
    YOLANDA GONZALEZ, SILVIA GUZMÁN-BELTRÁN, LAURA E. CARRETO-BINAGHI AND ESMERALDA JUÁREZ
    5. Vaccine delivery systems against tuberculosis
    RUPAL OJHA, RAJAN KUMAR PANDEY AND VIJAY KUMAR PRAJAPATI
    6. Inhalable polymeric dry powders for antituberculosis drug delivery
    SUNEERA ADLAKHA, KALPESH VAGHASIYA, ANKUR SHARMA, EUPA RAY AND RAHUL KUMAR VERMA
    7. Liposomes-and niosomes-based drug delivery systems for tuberculosis treatment
    ALI IBRAHIM BEKRAKI
    8. Polymer-based nanoparticles as delivery systems for treatment and vaccination of tuberculosis
    MOHSEN TAFAGHODI, FARZAD KHADEMI, FARIDEH SHIEHZADEH AND ZOHREH FIROZI
    9. Nanotechnology-based approaches for tuberculosis treatment
    MOHAMAD MOSA MUBARAK AND ZAHOOR AHMAD
    10. Dendrimer-based drug delivery systems for tuberculosis treatment
    RAHUL SHUKLA, AAKRITI SETHI, MAYANK HANDA, MRADUL MOHAN, PRASHANT KESHARWANI AND PUSHPENDRA K. TRIPATHI
    11. Polymeric micelle-based drug delivery systems for tuberculosis treatment
    BAPI GORAIN, HIRA CHOUDHURY, SREENIVAS PATRO AND PRASHANT KESHARWANI
    12. Nanostructured lipid carrier-based drug delivery systems for tuberculosis treatment
    SIMONE PINTO CARNEIRO AND ORLANDO DAVID HENRIQUE DOS SANTOS
    13. DNA markers and nano-biosensing approaches for tuberculosis diagnosis
    AMAL RABTI, AMAL RAOUAFI AND NOUREDDINE RAOUAFI
    14. Recent advancement and future perspective for the treatment of multidrug-resistant tuberculosis
    Noorsuzana Mohd Shariff
    15. Nanotechnology approach in conquering anti-TB resistance
    B.D. NOVITA

Details

No. of pages:
284
Language:
English
Copyright:
© Academic Press 2020
Published:
19th June 2020
Imprint:
Academic Press
Paperback ISBN:
9780128198117

About the Editor

Prashant Kesharwani

Dr. Prashant Kesharwani is Assistant Professor at Department of Pharmaceutics, School of Pharmaceutical Education and Research, Jamia Hamdard, New Delhi, India. He received his doctoral degree in Pharmaceutical Sciences from the Dr H.S. Gour University (Sagar, India) with Prof N.K Jain’s group. After his doctorate, he worked as postdoctoral fellows in the Wayne State University, Detroit (Michigan, USA). Dr. Kesharwani subsequently joined the School of Pharmacy, International Medical University (Malaysia) as lecturer in Pharmaceutical Technology. Subsequently he joined Central Drug Research Institute (CDRI), Lucknow as Ramanujan Fellow. He is a recipient of several internationally acclaimed awards. He has also received many research grants from various funding agencies of Government of India (GoI) i.e. Science and Engineering Research Board (SERB), Indian Council of Medical Research (ICMR), and University Grants Commission (UGC). An overarching goal of his current research is the development of nano-engineered drug delivery systems for cancer through with prime focus on dendrimer and polymeric nanomicelles mediated drug delivery systems. Dr. Kesharwani is a co-author on more than 140 publications in high impact factor international journals and 7 international books with total citations of more than 5000 (h index is 36 and i-10 index is 92 as per Google Scholar).

Affiliations and Expertise

Assistant Professor, Department of Pharmaceutics, School of Pharmaceutical Education and Research, Jamia Hamdard, New Delhi, India

Ratings and Reviews